Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humans
- PMID: 15905073
- DOI: 10.1016/j.bbadis.2005.04.002
Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humans
Abstract
ATB(0,+) (SLC6A14) is a Na(+)/Cl(-)-coupled arginine transporter expressed at low levels in normal colon. Arginine is an essential amino acid for tumor cells. Arginine is also the substrate for nitric oxide synthases (NOSs). Since arginine and arginine-derived nitric oxide (NO) play a critical role in cancer, we examined the expression of ATB(0,+) in colorectal cancer. Paired normal and cancer tissues from colectomy specimens of 10 patients with colorectal cancer and from the liver tissue of one patient with hepatic metastasis from a colonic primary were used for the analysis of the levels of ATB(0,+) mRNA, inducible NOS (iNOS) mRNA and the corresponding proteins. Tissues samples from the colon, liver, and lymph nodes of an additional patient with metastatic colon cancer were analyzed for ATB(0,+) protein alone. We also examined the levels of nitrotyrosylated proteins. The ATB(0,+) mRNA increased 22.9+/-3.0-fold in colorectal cancer compared to normal tissue and the increase was evident in each of the 10 cases examined. iNOS mRNA increased 5.2+/-1.1-fold in cancer specimens. The changes in mRNA levels were associated with an increase in ATB(0,+), iNOS, and nitrotyrosylated proteins. The increased expression of ATB(0,+) and iNOS was also demonstrated in liver and lymph node specimens with metastases from colonic primaries. This study strongly suggests that the upregulation of ATB(0,+) may have a pathogenic role in colorectal cancer. Since ATB(0,+) is a versatile transporter not only for arginine but also for several drugs including NOS inhibitors, these findings have significant clinical and therapeutic relevance.
Similar articles
-
Up-regulation of the amino acid transporter ATB(0,+) (SLC6A14) in carcinoma of the cervix.Gynecol Oncol. 2006 Jan;100(1):8-13. doi: 10.1016/j.ygyno.2005.08.016. Epub 2005 Sep 15. Gynecol Oncol. 2006. PMID: 16168467
-
Increased expression of inducible nitric oxide synthase for human buccal squamous-cell carcinomas: immunohistochemical, reverse transcription-polymerase chain reaction (RT-PCR) and in situ RT-PCR studies.Head Neck. 2002 Oct;24(10):925-32. doi: 10.1002/hed.10131. Head Neck. 2002. PMID: 12369071
-
Increased in situ expression of nitric oxide synthase in human colorectal cancer.Virchows Arch. 2000 Feb;436(2):109-14. doi: 10.1007/pl00008208. Virchows Arch. 2000. PMID: 10755599
-
Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs.Curr Drug Targets Immune Endocr Metabol Disord. 2005 Dec;5(4):357-64. doi: 10.2174/156800805774912953. Curr Drug Targets Immune Endocr Metabol Disord. 2005. PMID: 16375689 Review.
-
The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis.AAPS J. 2017 Dec 4;20(1):12. doi: 10.1208/s12248-017-0164-7. AAPS J. 2017. PMID: 29204754 Review.
Cited by
-
Association between Metabolites and the Risk of Lung Cancer: A Systematic Literature Review and Meta-Analysis of Observational Studies.Metabolites. 2020 Sep 5;10(9):362. doi: 10.3390/metabo10090362. Metabolites. 2020. PMID: 32899527 Free PMC article. Review.
-
Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer.BMC Cancer. 2022 Jul 30;22(1):833. doi: 10.1186/s12885-022-09935-0. BMC Cancer. 2022. PMID: 35907820 Free PMC article.
-
Amino acid metabolism genes associated with immunotherapy responses and clinical prognosis of colorectal cancer.Front Mol Biosci. 2022 Aug 5;9:955705. doi: 10.3389/fmolb.2022.955705. eCollection 2022. Front Mol Biosci. 2022. PMID: 35992263 Free PMC article.
-
Transporter-Targeted Nano-Sized Vehicles for Enhanced and Site-Specific Drug Delivery.Cancers (Basel). 2020 Oct 1;12(10):2837. doi: 10.3390/cancers12102837. Cancers (Basel). 2020. PMID: 33019627 Free PMC article. Review.
-
Identification of an Amino Acid Metabolism Reprogramming Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Colon Cancer.Appl Biochem Biotechnol. 2024 Sep 2. doi: 10.1007/s12010-024-05049-4. Online ahead of print. Appl Biochem Biotechnol. 2024. PMID: 39222169
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases